Biomarin Pharmaceutical (BMRN) Q2 2026 Earnings

May 4Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.28
0.22
0.73
1.23

Details

Expected EPS
0.692105
Actual EPS
0.76
Surprise EPS
0.07
Surprise Percent
+9.81%

Description

⁨Biomarin Pharmaceutical⁩ (⁦BMRN⁩) has reported earnings of ⁦0.76⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts